BioCorRx (BICX) EBIAT (2016 - 2025)
Historic EBIAT for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to -$1.9 million.
- BioCorRx's EBIAT fell 2675.88% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year decrease of 850.05%. This contributed to the annual value of -$5.2 million for FY2024, which is 3823.41% down from last year.
- As of Q3 2025, BioCorRx's EBIAT stood at -$1.9 million, which was down 2675.88% from -$1.4 million recorded in Q2 2025.
- In the past 5 years, BioCorRx's EBIAT registered a high of -$851764.0 during Q1 2025, and its lowest value of -$1.9 million during Q3 2025.
- Moreover, its 5-year median value for EBIAT was -$1.2 million (2021), whereas its average is -$1.2 million.
- As far as peak fluctuations go, BioCorRx's EBIAT soared by 4034.38% in 2022, and later crashed by 7444.09% in 2024.
- BioCorRx's EBIAT (Quarter) stood at -$1.2 million in 2021, then grew by 3.2% to -$1.2 million in 2022, then increased by 16.68% to -$969009.0 in 2023, then decreased by 26.69% to -$1.2 million in 2024, then crashed by 56.23% to -$1.9 million in 2025.
- Its EBIAT was -$1.9 million in Q3 2025, compared to -$1.4 million in Q2 2025 and -$851764.0 in Q1 2025.